Waterloo Capital’s Amgen AMGN Stock Holding History
Bought
Maintained
Sold
Other funds holding AMGN
Waterloo Capital's AMGN Position: Q2 2026 in Review
Waterloo Capital increased its Amgen (AMGN) stake by 10% in Q2 2026, buying an estimated $41.8K and bringing the position to 1,310 shares worth $474K. The position accounts for 0.03% of the portfolio, ranked #362.
Waterloo Capital first reported a position in AMGN in Q2 2024 and has held it in 8 quarters since. The position peaked at $523K in Q4 2025. 3,164 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.
- Waterloo Capital held 1,310 shares of Amgen worth $474K as of Q2 2026.
- Waterloo Capital bought 122 Amgen shares in Q2 2026, an estimated $41.8K.
- Amgen made up 0.03% of Waterloo Capital's portfolio in Q2 2026, its #362 holding.
- Waterloo Capital first reported a position in Amgen in Q2 2024 and has held it in 8 quarters since.
- Waterloo Capital's Amgen position peaked at $523K in Q4 2025.
- 3,164 funds tracked by Wall St. Rank held Amgen as of Q2 2026.
Based on Waterloo Capital's 13F filing for Q2 2026, filed 29 Jul 2026.